This study found that the recent change to remove race from the calculation of estimated glomerular filtration rate (eGFR) may incorrectly label potential donors who are Black as having chronic kidney ...

Annual health checkups regularly include urine tests that serve several purposes, including checking for symptoms of kidney disease. The presence of albumin in the urine is one indicator as is ...

Please provide your email address to receive an email when new articles are posted on . Newer eGFR calculations that do not consider race show a link between kidney function and dementia. Equations ...

The new equation appears more accurate than the race-free 2021 CKD-EPI equation, according to investigators. The European Kidney Function Consortium (EKFC) has developed a new race- and sex-free ...

A systematic review found that alternative approaches to calculating estimated glomerular filtration rate (eGFR) were worth looking into to properly account for diversity in populations. A review ...

BOSTON -- Some equations used to calculate estimated glomerular filtration rate (eGFR) may alter chemotherapy dosing in cancer patients, a prospective study indicated. Nearly 300 adults beginning ...

It is increasingly recognized that galactose-deficient IgA in the glomerulus activates the alternative complement system and drives IgA nephropathy, including in the tubules and interstitium, leading ...

A race-free revision of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation for calculating estimated glomerular filtration rate (eGFR), introduced in September 2021, has rapidly ...

Medications that reduce blood pressure and improve glycemia may preserve kidney function over time despite initial eGFR dips, ...

The symptoms of many kidney diseases are not obvious. When symptoms do appear, there may have been a lot of damage done. For this reason, GFR is regarded as an important early warning marker. Doctors ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...